|
1
|
Höckel M and Vaupel P: Tumor hypoxia:
Definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Briançon-Marjollet A, Pépin JL, Weiss JW,
Lévy P and Tamisier R: Intermittent hypoxia upregulates serum VEGF.
Sleep Med. 15:1425–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ziche M and Gullino PM: Angiogenesis and
neoplastic progression in vitro. J Natl Cancer Inst. 69:483–487.
1982.PubMed/NCBI
|
|
4
|
Langsenlehner U, Hofmann G, Renner W,
Gerger A, Krenn-Pilko S, Thurner EM, Krippl P and Langsenlehner T:
Association of vascular endothelial growth factor - a gene
polymorphisms and haplotypes with breast cancer metastases. Acta
Oncol. 54:368–376. 2015. View Article : Google Scholar
|
|
5
|
Semenza GL: Intratumoral hypoxia,
radiation resistance, and HIF-1. Cancer Cell. 5:405–406. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lara PC, Lloret M, Clavo B, Apolinario RM,
Henríquez-Hernández LA, Bordón E, Fontes F and Rey A: Severe
hypoxia induces chemo-resistance in clinical cervical tumors
through MVP over-expression. Radiat Oncol. 4:292009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ratcliffe PJ, O'Rourke JF, Maxwell PH and
Pugh CW: Oxygen sensing, hypoxia-inducible factor-1 and the
regulation of mammalian gene expression. J Exp Biol. 201:1153–1162.
1998.PubMed/NCBI
|
|
8
|
Srinivas V, Zhang LP, Zhu XH and Caro J:
Characterization of an oxygen/redox-dependent degradation domain of
hypoxia-inducible factor alpha (HIF-alpha) proteins. Biochem
Biophys Res Commun. 260:557–561. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reddy KR, Guan Y, Qin G, Zhou Z and Jing
N: Combined treatment targeting HIF-1α and Stat3 is a potent
strategy for prostate cancer therapy. Prostate. 71:1796–1809. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Warfel NA and El-Deiry WS: HIF-1 signaling
in drug resistance to chemotherapy. Curr Med Chem. 21:3021–3028.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Noche RR, Lu PN, Goldstein-Kral L, Glasgow
E and Liang JO: Circadian rhythms in the pineal organ persist in
zebrafish larvae that lack ventral brain. BMC Neurosci. 12:72011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
León J, Casado J, Jiménez Ruiz SM, Zurita
MS, González-Puga C, Rejón JD, Gila A, Muñoz de Rueda P, Pavón EJ,
Reiter RJ, et al: Melatonin reduces endothelin-1 expression and
secretion in colon cancer cells through the inactivation of FoxO-1
and NF-κβ. J Pineal Res. 56:415–426. 2014. View Article : Google Scholar
|
|
13
|
Yang Y, Sun Y, Yi W, Li Y, Fan C, Xin Z,
Jiang S, Di S, Qu Y, Reiter RJ, et al: A review of melatonin as a
suitable antioxidant against myocardial ischemia-reperfusion injury
and clinical heart diseases. J Pineal Res. 57:357–366. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lopes JR, Maschio LB, Jardim-Perassi BV,
Moschetta MG, Ferreira LC, Martins GR, Gelaleti GB and De Campos
Zuccari DA: Evaluation of melatonin treatment in primary culture of
canine mammary tumors. Oncol Rep. 33:311–319. 2015.
|
|
15
|
Cutando A, Aneiros-Fernández J,
López-Valverde A, Arias-Santiago S, Aneiros-Cachaza J and Reiter
RJ: A new perspective in oral health: Potential importance and
actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the
oral cavity. Arch Oral Biol. 56:944–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carocci A, Catalano A and Sinicropi MS:
Melatonergic drugs in development. Clin Pharmacol. 6:127–137.
2014.PubMed/NCBI
|
|
17
|
Wiesenberg I, Missbach M and Carlberg C:
The potential role of the transcription factor RZR/ROR as a
mediator of nuclear melatonin signaling. Restor Neurol Neurosci.
12:143–150. 1998.
|
|
18
|
Ekmekcioglu C: Melatonin receptors in
humans: Biological role and clinical relevance. Biomed
Pharmacother. 60:97–108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karamitri A, Vincens M, Chen M and Jockers
R: Involvement of melatonin MT2 receptor mutants in type
2 diabetes development. Med Sci. 29:778–784. 2013.In French.
|
|
20
|
Karasek M, Carrillo-Vico A, Guerrero JM,
Winczyk K and Pawlikowski M: Expression of melatonin MT(1) and
MT(2) receptors, and ROR alpha(1) receptor in transplantable murine
Colon 38 cancer. Neuro Endocrinol Lett. 23(Suppl 1): 55–60.
2002.PubMed/NCBI
|
|
21
|
Winczyk K, Pawlikowski M, Guerrero JM and
Karasek M: Possible involvement of the nuclear RZR/ROR-alpha
receptor in the antitumor action of melatonin on murine Colon 38
cancer. Tumour Biol. 23:298–302. 2002. View Article : Google Scholar
|
|
22
|
Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS,
Chen CY, Lee EO and Kim SH: Sphingosine kinase 1 pathway is
involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3
prostate cancer cells. J Pineal Res. 51:87–93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Liu Q, Wang F, Ling EA, Liu S,
Wang L, Yang Y, Yao L, Chen X, Wang F, et al: Melatonin antagonizes
hypoxia-mediated glioblastoma cell migration and invasion via
inhibition of HIF-1α. J Pineal Res. 55:121–130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paroni R, Terraneo L, Bonomini F, Finati
E, Virgili E, Bianciardi P, Favero G, Fraschini F, Reiter RJ,
Rezzani R, et al: Antitumour activity of melatonin in a mouse model
of human prostate cancer: Relationship with hypoxia signalling. J
Pineal Res. 57:43–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Zheng J, Xu R, Zhang Y, Gu L, Dong
J, Zhu Y, Zhou R, Zheng L, Zhang X, et al: Melatonin suppresses
hypoxia-induced migration of HUVECs via inhibition of ERK/Rac1
activation. Int J Mol Sci. 15:14102–14121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu H, Xu L, Wei JE, Xie MR, Wang SE and
Zhou RX: Role of CD4+ CD25+ regulatory T
cells in melatonin-mediated inhibition of murine gastric cancer
cell growth in vivo and in vitro. Anat Rec. 294:781–788. 2011.
View Article : Google Scholar
|
|
27
|
Xu L, Liu H, Zhang H, Wang RX, Song J and
Zhou RX: Growth-inhibitory activity of melatonin on murine
foregastric carcinoma cells in vitro and the underlying molecular
mechanism. Anat Rec. 296:914–920. 2013. View Article : Google Scholar
|
|
28
|
Ye LY, Zhang Q, Bai XL, Pankaj P, Hu QD
and Liang TB: Hypoxia-inducible factor 1α expression and its
clinical significance in pancreatic cancer: A meta-analysis.
Pancreatology. 14:391–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
García JJ, López-Pingarrón L,
Almeida-Souza P, Tres A, Escudero P, García-Gil FA, Tan DX, Reiter
RJ, Ramírez JM and Bernal-Pérez M: Protective effects of melatonin
in reducing oxidative stress and in preserving the fluidity of
biological membranes: A review. J Pineal Res. 56:225–237. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carlberg C and Wiesenberg I: The orphan
receptor family RZR/ROR, melatonin and 5-lipoxygenase: An
unexpected relationship. J Pineal Res. 18:171–178. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK,
Bae MH, Yoo MA, Song EJ, Lee KJ and Kim KW: Regulation and
destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell.
111:709–720. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Geoffroy MC and Hay RT: An additional role
for SUMO in ubiquitin-mediated proteolysis. Nat Rev Mol Cell Biol.
10:564–568. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Q, Xia N, Li T, Xu Y, Zou Y, Zuo Y,
Fan Q, Bawa-Khalfe T, Yeh ET and Cheng J: SUMO-specific protease 1
promotes prostate cancer progression and metastasis. Oncogene.
32:2493–2498. 2013. View Article : Google Scholar
|
|
34
|
Gu J, Fan Y, Liu X, Zhou L, Cheng J, Cai R
and Xue S: SENP1 protects against myocardial ischaemia/reperfusion
injury via a HIF1α-dependent pathway. Cardiovasc Res. 104:83–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park SY, Jang WJ, Yi EY, Jang JY, Jung Y,
Jeong JW and Kim YJ: Melatonin suppresses tumor angiogenesis by
inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res.
48:178–184. 2010. View Article : Google Scholar : PubMed/NCBI
|
